Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Hospitalized patients with histologically or cytologically confirmed diagnosis of solid tumor malignancy, lymphoma, or multiple myeloma and who are at high risk for a venous thromboembolism will be randomized to standard dose versus intermediate dose enoxaparin.
Epistemonikos ID: 6c46036ea69983f6a6e85b7e661ac392f8fd2ede
First added on: May 12, 2024